ADAPTIMMUNE THERAPEUTICS PLC's ticker is and the CUSIP is 00653A957. A total of 2 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 700 | -97.0% | 0.00% | – |
| Q2 2023 | $21 | -16.0% | 23,200 | -2.1% | 0.00% | – |
| Q1 2023 | $25 | – | 23,700 | +23600.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 100 | -95.5% | 0.00% | – |
| Q2 2022 | $3,000 | -72.7% | 2,200 | -62.1% | 0.00% | – |
| Q1 2022 | $11,000 | +266.7% | 5,800 | +544.4% | 0.00% | – |
| Q4 2021 | $3,000 | -92.5% | 900 | -90.4% | 0.00% | – |
| Q3 2021 | $40,000 | 0.0% | 9,400 | 0.0% | 0.00% | – |
| Q2 2021 | $40,000 | -68.5% | 9,400 | +3800.4% | 0.00% | – |
| Q1 2021 | $127,000 | +159.2% | 241 | +164.8% | 0.00% | – |
| Q4 2020 | $49,000 | +2350.0% | 91 | +2933.3% | 0.00% | – |
| Q3 2020 | $2,000 | -99.7% | 3 | -99.5% | 0.00% | -100.0% |
| Q2 2020 | $601,000 | +4908.3% | 601 | +1235.6% | 0.00% | – |
| Q1 2020 | $12,000 | +50.0% | 45 | +125.0% | 0.00% | – |
| Q1 2019 | $8,000 | +60.0% | 20 | +100.0% | 0.00% | – |
| Q4 2018 | $5,000 | – | 10 | +233.3% | 0.00% | – |
| Q1 2018 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 91 | $49,000 | 0.00% |